Contingency Management for Smoking Cessation
Trial Summary
What is the purpose of this trial?
This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Contingency Management for smoking cessation?
Research shows that using financial incentives, like prizes or vouchers, can help people quit smoking by rewarding them for not smoking. Studies found that people are more likely to stop smoking when they receive rewards for staying smoke-free, and this approach has been effective in various settings, including with pregnant women and socioeconomically disadvantaged individuals.12345
Is contingency management for smoking cessation safe for humans?
How does the contingency management treatment for smoking cessation differ from other treatments?
Contingency management for smoking cessation is unique because it uses incentives, like money or prizes, to encourage people to quit smoking. This approach is different from traditional methods as it directly rewards individuals for maintaining abstinence, which can increase motivation and participation.123910
Research Team
Benjamin Toll, PhD
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for adult smokers diagnosed with or suspected to have operable cancer, who are about to undergo surgery. Participants must smoke at least one cigarette daily and speak English. Those using alternative nicotine products, pregnant women, or individuals with unstable psychiatric/medical conditions cannot join.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive standard smoking cessation therapy including counseling and the nicotine patch. Half of the participants receive a novel smoking cessation treatment.
Follow-up
Participants are monitored for smoking abstinence through self-report, Carbon Monoxide Breath Monitoring, and Anabasine testing.
Treatment Details
Interventions
- Contingency Management (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor
Dr. Erik Summers
Medical University of South Carolina
Chief Medical Officer
MD from University of Alabama at Birmingham
Dr. Patrick J. Cawley
Medical University of South Carolina
Chief Executive Officer
MD, MBA
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School